ENANTA PHARMACEUTICALS, INC
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $375.4M
Liabilities Breakdown FY2022
Total Liabilities: $54.1M
Asset Breakdown
Total Assets: $375.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $44.0M | 11.7% |
| Accounts Receivable | $20.3M | 5.4% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $6.2M | 1.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $304.9M | 81.2% |
Liabilities Breakdown
Total Liabilities: $54.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.0M | 11.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $48.1M | 88.9% |